Veradermics MANE
NYSE MANE
$116.74 -0.51 (-0.43%)
At close: Oct 2, 2026 · 4:00 PM EDT

Veradermics (MANE) Cash from Investing Activities (2025 - 2026)

Updated

Veradermics (MANE) recorded Cash from Investing Activities of -$277.29 million in Q2 2026, compared with -$8.33 million a year earlier.

Analysis

Veradermics (MANE) Cash from Investing Activities (2025 - 2026) Analysis & Trends

On a TTM basis, Veradermics' Cash from Investing Activities came in at -$402.67 million as of Jun 30, 2026; for FY2025, it came in at -$118.86 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -15.40 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -1.11 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -1.20 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -5.60 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.11 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -2.91 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -569.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -10.35 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.11 Bn
10 Veradermics 4.88 Bn 4.88 Bn - -277.29 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -277.29 Mn
Mar 31, 2026 -101.30 Mn
Jun 30, 2025 -8.33 Mn
Mar 31, 2025 -15.75 Mn
API Access

Veradermics Cash from Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=MANE&period=max&api_key=YOUR_API_KEY